Goal of the analysis:
Proactively identify potential failure modes in a medical device’s design or processes, assess their effects and causes, and prioritize corrective actions to reduce risk to patients, users, and the organization.
Data required:
- Detailed process maps or device design specifications
- Historical data on failures, complaints, and service records (if available)
- Risk management files (for example, ISO 14971 documentation)
- Cross-functional team input (engineering, quality, manufacturing, clinical)
- Severity, occurrence, and detection criteria tailored to the device or process
- Any relevant standards or regulatory guidance for risk analysis
Detailed step-by-step instruction on how to conduct the analysis:
- Assemble a cross-functional team. Include representatives from design, manufacturing, quality, regulatory, and clinical teams to capture diverse perspectives.
- Define the scope of the FMEA. Determine whether the analysis targets design (Design FMEA) or manufacturing processes (Process FMEA). Outline system boundaries, assumptions, and level of detail required.
- List process steps or design elements. Map each stage of the device’s lifecycle (for example, design inputs, assembly, packaging) or each component of the device design.
- Identify possible failure modes. For each step or component, brainstorm ways it could fail to perform its intended function.
- Determine potential effects of failure. Describe the impact on device performance, patient safety, and downstream processes.
- Assign severity, occurrence, and detection ratings. Use an agreed rating scale (for example, 1–10) to estimate how serious the effect is, how likely the failure is to occur, and how easily it can be detected before harm occurs.
- Calculate Risk Priority Number (RPN). RPN = Severity x Occurrence x Detection. A high RPN indicates a higher-priority failure mode that needs immediate attention.
- Develop corrective actions or mitigation strategies. Focus on high-RPN items first, brainstorming ways to reduce severity, occurrence, or improve detection. Document action owners and deadlines.
- Recalculate RPN after actions. Once mitigation steps are in place, reassess the risk levels. Update the FMEA document accordingly to reflect improvements.
- Monitor and review. Treat FMEA as a living document, revisiting it periodically (for example, during design changes or process improvements).
Format of the output of analysis:
- An FMEA spreadsheet or table listing each failure mode, effect, cause, severity, occurrence, detection, RPN, and recommended actions
- A summary report detailing key findings, top risks, and the action plan to address them
- Visual aids (for example, process flow diagrams, charts) illustrating where critical failure modes reside
- An updated risk management file integrating FMEA results and any new mitigation measures
How to interpret results:
- Higher RPN values highlight the failure modes that carry the greatest overall risk, guiding resource allocation and urgency for corrective action.
- Repeatedly high occurrence or severity ratings could indicate a systemic flaw needing design or process reengineering.
- Reductions in RPN following improvements demonstrate effective mitigation, but continuous monitoring ensures long-term risk control.
Steps a company can take to improve on this measure:
- Standardize rating criteria (severity, occurrence, detection) to maintain consistency across projects and teams.
- Involve cross-functional experts early, ensuring comprehensive coverage of potential failure modes.
- Integrate FMEA outcomes into the broader risk management and quality system (for example, CAPA, design controls).
- Conduct periodic training so all team members understand FMEA concepts and remain engaged in ongoing risk reduction efforts.
- Update FMEA documents whenever there are changes to the design, materials, or manufacturing process to keep the risk profile current.
Request the PDF Download of How to Analyze a Medical Devices Company
Menu of the analyses:
Table of Contents
A. Regulatory & Compliance
- Regulatory Pathway Analysis
- Regulatory Compliance and Quality Management Systems Review
- Labeling and Unique Device Identification (UDI) Compliance Assessment
- Device Classification and Product Code Analysis
- Combination Product Regulatory Strategy
- EU MDR/IVDR Compliance Gap Analysis
- MDSAP (Medical Device Single Audit Program) Readiness and Gap Analysis
- OTC vs. Prescription Device Classification Feasibility
- Reprocessing and Re-Manufacturing Compliance Assessment
- Software Update Lifecycle (IEC 62304) Compliance Review
B. Clinical & Post-Market
- Clinical Evidence Review
- Post-Market Surveillance and Vigilance
- CRO and Clinical Site Management Efficiency Analysis
- Real-World Evidence Generation Strategy for Device Performance
- Clinical Evidence Gap Analysis
- Comparative Efficacy and Safety Benchmarking vs. Standard of Care
- Field Safety Corrective Action and Recall Readiness Evaluation
- Patient Engagement and Compliance Tracking for Home-Use Devices
C. Reimbursement & Market Access
D. Product Development & Lifecycle
E. Operations & Supply Chain
F. Risk Management & Quality
G. Commercial Strategy & Marketing
H. Technology & Innovation
- Software as a Medical Device (SaMD) and Cybersecurity Risk Assessment
- Device Tracking and Traceability Program Analysis
- Human Factors Engineering and Usability Evaluation
- Material Compatibility and Biomaterial Selection Analysis
- Clinical Data Integration with Wearables and IoT Devices
- Calibration and Maintenance Program for Reusable Devices
- In-Vitro Diagnostic (IVD) Connectivity with Laboratory Information Systems (LIS) Workflow Analysis
- Remote Servicing and Maintenance Approach for Connected Medical Devices
I. Intellectual Property
J. Sustainability & Environmental Impact